Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:1568-1573
doi: 10.1161/01.STR.0000017220.78722.D7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurl, S.
Right arrow Articles by Salonen, J.T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurl, S.
Right arrow Articles by Salonen, J.T.
Related Collections
Right arrow Nutrition
Right arrow Epidemiology
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors for Stroke

(Stroke. 2002;33:1568.)
© 2002 American Heart Association, Inc.


Original Contributions

Plasma Vitamin C Modifies the Association Between Hypertension and Risk of Stroke

S. Kurl, MD; T.P. Tuomainen, MD; J.A. Laukkanen, MD; K. Nyyssönen, PhD; T. Lakka, MD, PhD; J. Sivenius, MD, PhD J.T. Salonen, MD, PhD, MscPH

From the Research Institute of Public Health (S.K., T.P.T., J.A.L., K.N., T.L., J.T.S.), Department of Community Health and General Practice and Inner Savo Health Centre (J.T.S.), and Department of Neuroscience and Neurology and Brain Research and Rehabilitation Centre Neuron (J.S.), University of Kuopio, Kuopio, Finland.

Correspondence to Professor J.T. Salonen, Research Institute of Public Health, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland. E-mail jukka.salonen{at}uku.fi

Background and Purpose There are no prospective studies to determine whether plasma vitamin C modifies the risk of stroke among hypertensive and overweight individuals. We sought to examine whether plasma vitamin C modifies the association between overweight and hypertension and the risk of stroke in middle-aged men from eastern Finland.

Methods We conducted a 10.4-year prospective population-based cohort study of 2419 randomly selected middle-aged men (42 to 60 years) with no history of stroke at baseline examination. A total of 120 men developed a stroke, of which 96 were ischemic and 24 hemorrhagic strokes.

Results Men with the lowest levels of plasma vitamin C (<28.4 µmol/L, lowest quarter) had a 2.4-fold (95% CI, 1.4 to 4.3; P=0.002) risk of any stroke compared with men with highest levels of plasma vitamin C (>64.96 µmol/L, highest quarter) after adjustment for age and examination months. An additional adjustment for body mass index, systolic blood pressure, smoking, alcohol consumption, serum total cholesterol, diabetes, and exercise-induced myocardial ischemia attenuated the association marginally (relative risk, 2.1; 95% CI, 1.2 to 3.8; P=0.01). Adjustment for prevalent coronary heart disease and atrial fibrillation did not attenuate the association any further. Furthermore, hypertensive men with the lowest vitamin C levels (<28.4 µmol/L) had a 2.6-fold risk (95% CI, 1.52 to 4.48; P<0.001), and overweight men (>=25 kg/m2) with low plasma vitamin C had a 2.7-fold risk (95% CI, 1.48 to 4.90; P=0.001) for any stroke after adjustment for age, examination months, and other risk factors.

Conclusions Low plasma vitamin C was associated with increased risk of stroke, especially among hypertensive and overweight men.


Key Words: ascorbic acid • hypertension • obesity • preventive medicine • risk • stroke




This article has been cited by other articles:


Home page
Scand J Public HealthHome page
T. Tynes and T. Haldorsen
Mortality in the Sami population of North Norway, 1970 98
Scand J Public Health, May 1, 2007; 35(3): 306 - 312.
[Abstract] [PDF]


Home page
StrokeHome page
S. Kurl, J. A. Laukkanen, L. Niskanen, D. Laaksonen, J. Sivenius, K. Nyyssonen, and J. T. Salonen
Metabolic Syndrome and the Risk of Stroke in Middle-Aged Men
Stroke, March 1, 2006; 37(3): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. A. Simon, M. A. Murtaugh, M. D. Gross, C. M. Loria, S. B. Hulley, and D. R. Jacobs Jr.
Relation of Ascorbic Acid to Coronary Artery Calcium: The Coronary Artery Risk Development in Young Adults Study
Am. J. Epidemiol., March 15, 2004; 159(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. W. Lee, H. J. Lee, Y.-J. Surh, and C. Y. Lee
Vitamin C and cancer chemoprevention: reappraisal
Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1074 - 1078.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Sauvaget, J. Nagano, N. Allen, and K. Kodama
Vegetable and Fruit Intake and Stroke Mortality in the Hiroshima/Nagasaki Life Span Study
Stroke, October 1, 2003; 34(10): 2355 - 2360.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Matsumoto, L. V. d'uscio, D. Eguchi, M. Akiyama, L. A. Smith, and Z. S. Katusic
Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 103 - 108.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z. S. Katusic
Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity
Circ. Res., January 10, 2003; 92(1): 88 - 95.
[Abstract] [Full Text] [PDF]